|
ATHA |
Press Release |
Communiqué de presse |
01/04/2025 |
 Open Filing (167.15 Ko) |
|
ONCO |
CONDENSED INTERIM CONSOLIDATED FINANCIAL STATEMENTS For the three and nine months ended January 31, 2025 |
États financiers intermédiaires |
01/04/2025 |
Open Filing (239.82 Ko) |
|
ONCO |
FORM 5 QUARTERLY LISTING STATEMENT (Q3 - JAN 31, 2025) |
Déclaration d'inscription trimestrielle |
01/04/2025 |
Open Filing (801.99 Ko) |
|
ARQ |
CSE_Form_17B_Argo Gold MARCH 2025 Report_of_Purchases_for_Normal_Course_Issuer_Bid_April 1 2025 |
Report of Purchases Normal Course Issuer Bid |
01/04/2025 |
Open Filing (137.06 Ko) |
|
BBRD |
Monthly Progress Report (March 2025) |
Rapport d'activité mensuel |
01/04/2025 |
Open Filing (142.54 Ko) |
|
PM |
Monthly Progress Report (March 2025) |
Rapport d'activité mensuel |
01/04/2025 |
Open Filing (145.29 Ko) |
|
BIOV |
BioVaxys Technology Corp. - CSE Form 9 - Notice of Issuance or Proposed Issuance of Listed Securities |
Émission proposée des titres cotés |
01/04/2025 |
Open Filing (206.12 Ko) |
|
BIOV |
BioVaxys Technology Corp. Announces Debt Settlement Agreement |
Communiqué de presse |
01/04/2025 |
Open Filing (544.61 Ko) |
|
SHRC |
Form 7 - March 2025 |
Rapport d'activité mensuel |
01/04/2025 |
Open Filing (132.43 Ko) |
|
EPIC |
CSE Form 7 - March 2025 - Monthly Report |
Rapport d'activité mensuel |
01/04/2025 |
Open Filing (129.98 Ko) |
